Sonoma Pharmaceuticals   Report issue

For profit Phase 2 Phase 4
Founded: Petaluma CA United States (1999)
Status: No NME R&D (1999)

Organization Overview

First Clinical Trial
2007
NCT00516958
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Oculus Innovative Sciences | Oculus Innovative Sciences, Inc.